These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 34876062)

  • 1. High expression of eIF4E is associated with tumor macrophage infiltration and leads to poor prognosis in breast cancer.
    Li F; Sun H; Li Y; Bai X; Dong X; Zhao N; Meng J; Sun B; Zhang D
    BMC Cancer; 2021 Dec; 21(1):1305. PubMed ID: 34876062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NEFM DNA methylation correlates with immune infiltration and survival in breast cancer.
    Li D; Zhao W; Zhang X; Lv H; Li C; Sun L
    Clin Epigenetics; 2021 May; 13(1):112. PubMed ID: 34001208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bromodomain 4 is a potent prognostic marker associated with immune cell infiltration in breast cancer.
    Zhong L; Yang Z; Lei D; Li L; Song S; Cao D; Liu Y
    Basic Clin Pharmacol Toxicol; 2021 Jan; 128(1):169-182. PubMed ID: 32799413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of DRP1 as a prognostic factor correlated with immune infiltration in breast cancer.
    Liu B; Fan Y; Song Z; Han B; Meng Y; Cao P; Tan K
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107078. PubMed ID: 33049497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eukaryotic initiation factor 4E (eIF4E) and angiogenesis: prognostic markers for breast cancer.
    Zhou S; Wang GP; Liu C; Zhou M
    BMC Cancer; 2006 Sep; 6():231. PubMed ID: 17010208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ITGA5 is a prognostic biomarker and correlated with immune infiltration in gastrointestinal tumors.
    Zhu H; Wang G; Zhu H; Xu A
    BMC Cancer; 2021 Mar; 21(1):269. PubMed ID: 33711961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceruloplasmin correlates with immune infiltration and serves as a prognostic biomarker in breast cancer.
    Chen F; Han B; Meng Y; Han Y; Liu B; Zhang B; Chang Y; Cao P; Fan Y; Tan K
    Aging (Albany NY); 2021 Aug; 13(16):20438-20467. PubMed ID: 34413268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers.
    Pelekanou V; Villarroel-Espindola F; Schalper KA; Pusztai L; Rimm DL
    Breast Cancer Res; 2018 Dec; 20(1):154. PubMed ID: 30558648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of S1PR1 and its correlation with immune infiltrates in breast and lung cancers.
    Zhong L; Xie L; Yang Z; Li L; Song S; Cao D; Liu Y
    BMC Cancer; 2020 Aug; 20(1):766. PubMed ID: 32799825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TIMM8A is associated with dysfunction of immune cell in BRCA and UCEC for predicting anti-PD-L1 therapy efficacy.
    Zhu X; Yuan Z; Cheng S; Wang H; Liao Y; Zhou D; Wu Z
    World J Surg Oncol; 2022 Oct; 20(1):336. PubMed ID: 36207751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated analysis identifies TfR1 as a prognostic biomarker which correlates with immune infiltration in breast cancer.
    Chen F; Fan Y; Hou J; Liu B; Zhang B; Shang Y; Chang Y; Cao P; Tan K
    Aging (Albany NY); 2021 Sep; 13(17):21671-21699. PubMed ID: 34518441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SOX13 is a novel prognostic biomarker and associates with immune infiltration in breast cancer.
    Gao T; Jiang B; Zhou Y; He R; Xie L; Li Y
    Front Immunol; 2024; 15():1369892. PubMed ID: 38707897
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Li Y; Li F; Bai X; Li Y; Ni C; Zhao X; Zhang D
    Front Oncol; 2021; 11():658547. PubMed ID: 34094951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eukaryotic translation initiation factor 4E (eIF4E) expression is associated with breast cancer tumor phenotype and predicts survival after anthracycline chemotherapy treatment.
    Heikkinen T; Korpela T; Fagerholm R; Khan S; Aittomäki K; Heikkilä P; Blomqvist C; Carpén O; Nevanlinna H
    Breast Cancer Res Treat; 2013 Aug; 141(1):79-88. PubMed ID: 23974830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
    Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
    Front Immunol; 2019; 10():6. PubMed ID: 30761122
    [No Abstract]   [Full Text] [Related]  

  • 16. Integrated analysis identifies AQP9 correlates with immune infiltration and acts as a prognosticator in multiple cancers.
    Liu X; Xu Q; Li Z; Xiong B
    Sci Rep; 2020 Nov; 10(1):20795. PubMed ID: 33247170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Jagged1 promotes aromatase inhibitor resistance by modulating tumor-associated macrophage differentiation in breast cancer patients.
    Liu H; Wang J; Zhang M; Xuan Q; Wang Z; Lian X; Zhang Q
    Breast Cancer Res Treat; 2017 Nov; 166(1):95-107. PubMed ID: 28730338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Five Immune-Related lncRNAs Predicting Survival and Tumor Microenvironment Characteristics in Breast Cancer.
    Xiao R; Yang M; Tan Y; Ding R; Li D
    Comput Math Methods Med; 2021; 2021():6676692. PubMed ID: 33727952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibiting KLRB1 expression is associated with impairing cancer immunity and leading to cancer progression and poor prognosis in breast invasive carcinoma patients.
    He JR; Li D; Zhang QX; Liu T; Ding Y; Wu CY; Chen SS; Chen JL
    Aging (Albany NY); 2023 Nov; 15(22):13265-13286. PubMed ID: 37988189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients.
    Medrek C; Pontén F; Jirström K; Leandersson K
    BMC Cancer; 2012 Jul; 12():306. PubMed ID: 22824040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.